KATI MATHIS: Open Payments
NPI 1932727625 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 41 payments from 16 companies in 2025. Trend: 2023 $950 · 2024 $993 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $237 |
| GlaxoSmithKline, LLC. | 4 | $210 |
| Amgen Inc. | 4 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $64 |
| ANI Pharmaceuticals, Inc. | 2 | $59 |
| Radius Health, Inc. | 2 | $54 |
| TerSera Therapeutics LLC | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| PFIZER INC. | 2 | $38 |
Products named: BENLYSTA, SKYRIZI, RINVOQ, HYQVIA, PURIFIED CORTROPHIN GEL, Tymlos, Quzyttir, SAPHNELO.
Industry payments across SC — which companies pay providers there.
